CVE-2018-14789
3Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackepss 0.4%
exploitation probability
0.4%top 63% of all CVEs
observed exploitation
nono source reports it
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may allow an attacker to execute arbitrary code and escalate their level of privileges.
Affected products
Philips · IntelliSpace Cardiovascular (ISCV) products